Nk cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: Immunogene therapy using a highly secretable form of interleukin-15 gene transfer

Journal of Leukocyte Biology

Volumn 69, Issue 4, 2001, Pages 531-537

  Suzuki, Kazuhiro ^a   Nakazato, Haruki ^a   Matsui, Hiroshi ^a   Hasumi, Masaru ^a   Shibata, Yasuhiro ^a   Ito, Kazuto ^a   Fukabori, Yoshitatsu ^a   Kurokawa, Kohei ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Anti asialo GM1; Cellular immunity; Chimeric peptide; Murine IFN

Indexed keywords

CHIMERIC PROTEIN; CYTOKINE; GAMMA INTERFERON; GANGLIOSIDE ANTIBODY; GANGLIOTETRAOSYLCERAMIDE ANTIBODY; HUMAN GROWTH HORMONE; INTERLEUKIN 15; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SPLEEN CELL; SUPERNATANT; TREATMENT OUTCOME; TUMOR IMMUNITY; TUMOR NECROSIS;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CULTURE MEDIA, CONDITIONED; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, SYNTHETIC; HUMAN GROWTH HORMONE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0035074658     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Cancer statistics
2. International comparison of prostate cancer incidence and morbidity
3. Management of the urological patient
4. New treatment strategies for hormone refractory prostate cancer
5. The natural history of human prostate cancer
6. Regression of established pulmonary, metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant IL-2
7. Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo
8. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
9. Suppression of angiogenesis, tumorigenesis, and metastasis by human prostate cancer cells engineered to produce interferon-β
10. Role of interleukin 10 and transforming growth factor betal in the anigiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice
11. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pro-established lung metastases in an orthotopic model
12. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogen
13. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
14. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15
15. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
16. Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor
17. + hematopoietic progenitor cells
18. A potential role for interleukin-15 in the regulation of human natural killer cell survival
19. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
20. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1 + T cell receptor-alpha/beta+ (NK1 + T) cells, natural killer cells, and intestinal intraepithelial T cells
21. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
22. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15
23. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
24. Chemoattraction of human blood T lymphocytes by interleukin-15
25. IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo
26. Immunogene therapy of murine fibrosarcoma using IL-15 gene with high translation efficiency
27. Tumor cells engineered to secrete interleukin-15 augment anti-tumor immune responses in vivo
28. Molecular characterization of defective antigen processing in human prostate cancer
29. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma
30. Biology and clinical relevance of human natural killer cells
31. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels
32. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation
33. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides
34. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA
35. The 5′ untranslated region, signal peptide, and the cording sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control
36. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response
37. The human growth hormone gene family: Nucleotide sequences show recent divergence and predict a new polypeptide hormone
38. Interleukin 4 expressed in situ selectively alters thymocyte development
39. Dissimilar anti-turnout reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice
40. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokineactivated killer cells
41. Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms
42. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlated with secretion: Role of different signal peptides
43. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms
44. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2
45. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo
46. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro
47. Metastatic prostate cancer in a transgenic mouse
48. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model
49. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy